ARTICLE | Clinical News
AYX1: Phase IIb data
August 17, 2015 7:00 AM UTC
The double-blind, U.S. Phase IIb ADYX-003 trial in 120 patients who underwent knee replacement surgery showed that a single preoperative intrathecal injection of AYX1 plus standard of care (SOC) met t...